At Aptuit we understand that a successful drug development program is always underpinned by a successful formulation development program to develop a high quality drug product fit for purpose using the minimum quantity of drug substance. Our scientists offer a breadth of expertise and can develop a wide range of dosage forms by the use of experimental design methodology. Our scientists undertake each project with our clients’ expectations in mind and design formulations tailored to meet our clients’ specific end-product requirements.
We offer a wide variety of Formulation Development services to allow us to meet your drug development program needs, including the formulation of solid dosage forms and liquid dosage forms, precision dosing methods, including unrivalled expertise of method development for Xcelodose® 600 and 600S and autodose technologies, and the formulation development of parenteral dosage forms.
Our scientists have experience of providing both industry standard and novel solutions to your drug development program formulation issues, including development of immediate, modified and sustained release formulations, improvements in bioavailability of poorly soluble compounds by dosage form design, process transfer and scale-up of drug products to full scale manufacturing and the use of experimental design (DOE) to establish critical process parameters and ensure process robustness. We pride ourselves in the close relationship that our formulation development department has with our analytical method development group to ensure that the appropriate level and scope of testing is applied to each individual project.